|
CASD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.670100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.366820E-01 |
| Normal-vs-Stage2 |
7.396500E-02 |
| Normal-vs-Stage3 |
5.736400E-03 |
| Normal-vs-Stage4 |
2.824000E-03 |
| Stage1-vs-Stage2 |
3.941000E-01 |
| Stage1-vs-Stage3 |
9.765700E-02 |
| Stage1-vs-Stage4 |
4.329900E-02 |
| Stage2-vs-Stage3 |
7.850600E-01 |
| Stage2-vs-Stage4 |
5.783600E-01 |
| Stage3-vs-Stage4 |
6.939000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.596100E-02 |
| Normal-vs-AfricanAmerican |
6.148200E-01 |
| Normal-vs-Asian |
2.384200E-01 |
| Caucasian-vs-AfricanAmerican |
4.192200E-01 |
| Caucasian-vs-Asian |
5.604600E-01 |
| AfricanAmerican-vs-Asian |
7.572200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.903300E-03 |
| Normal-vs-Female |
5.019600E-02 |
| Male-vs-Female |
8.235800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.096800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.385900E-02 |
| Normal-vs-Age(61-80Yrs) |
7.445600E-04 |
| Normal-vs-Age(81-100Yrs) |
7.744300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.303200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.205740E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.553200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.800000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.948200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.878600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.074290E-02 |
| Classical-VS-Follicular |
4.15489999999741E-05 |
| Classical-VS-Other |
4.887200E-01 |
| Classical-VS-Normal |
3.872600E-01 |
| Tall-VS-Follicular |
5.040800E-01 |
| Tall-VS-Other |
6.933400E-01 |
| Tall-VS-Normal |
8.660200E-03 |
| Follicular-VS-Other |
5.177400E-01 |
| Follicular-VS-Normal |
3.049500E-04 |
| Other-VS-Normal |
2.898600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.339900E-03 |
| Normal-vs-N1 |
7.551800E-02 |
| N0-vs-N1 |
4.583800E-01 |
|
|
